SCHEMBL4989586

SCHEMBL4989586

COc1cc(NS(C)(=O)=O)c(O)cc1CC1=NCCN1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 12/20 0.42
ADRA1D P25100 10/20 0.42
ADRA1B P35368 10/20 0.42
ADRA2A P08913 8/20 0.42
HTR1B P28222 6/20 0.39
HTR1D P28221 4/20 0.39
ADRA2C P18825 7/20 0.37
RAD52 P43351 1/20 0.37
TAAR1 Q96RJ0 1/20 0.36
ADRA2B P18089 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2D6 P10635 2/20 0.36
TSHR P16473 2/20 0.36
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
HTR1A P08908 1/20 0.36
CHRM5 P08912 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4994047 0.90 ADRA1A (0.44) ADRA1AADRA1DADRA1BADRA2AHTR1B
SCHEMBL4986567 0.87 ADRA1A (0.47) ADRA1AADRA1DADRA1BADRA2AHTR1B
SCHEMBL14092057 0.86 ADRA1A (0.39) ADRA1AADRA1DADRA1BADRA2AHTR1B
SCHEMBL4989433 0.81 ADRA1A (0.44) ADRA1AADRA1DADRA1BADRA2AHTR1B
SCHEMBL4989442 0.80 ADRA1A (0.42) ADRA1AADRA1DADRA1BADRA2AHTR1B
SCHEMBL4994677 0.80 ADRA1A (0.47) ADRA1AADRA1DADRA1BADRA2AHTR1B
SCHEMBL4989420 0.80 KDM4E (0.53) ADRA1AADRA1DADRA1BADRA2AHTR1B
SCHEMBL4994698 0.77 HTR1B (0.51) ADRA1AADRA1DADRA1BADRA2AHTR1B
SCHEMBL5200788 0.77 HTR1B (0.51) ADRA1AADRA1DADRA1BADRA2AHTR1B
SCHEMBL5203274 0.77 ADRA1A (0.55) ADRA1AADRA1DADRA1BADRA2AHTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6756395-B2 CYCLIZATION OF N-(4-CYANOMETHYLPHENYL)METHANESULFONAMIDES WITH ETHYLENEDIAMINE TO FORM N-(4-IMIDAZOL-2-YLMETHYL)-PHENYL) -METHANESULFONAMIDES; INCONTINENCE, SEXUAL DYSFUNCTION, NASAL CONGESTION, AND CNS DISORDERS; ALPHA 1 ADRENERGIC AGONISTS ROCHE PALO ALTO LLC 2004-06-29 US claimed
US-7407980-B2 Imidazolinylmethyl aralkylsulfonamides ROCHE PALO ALTO LLC (US) 2008-08-05 US disclosed
US-7407980-B2 Imidazolinylmethyl aralkylsulfonamides ROCHE PALO ALTO LLC (US) 2008-08-05 US disclosed
US-7407980-B2 Imidazolinylmethyl aralkylsulfonamides ROCHE PALO ALTO LLC (US) 2008-08-05 US disclosed